TGA Group of Regulators business plan 2005-2006
TGA Group of Regulators business plan 2005-2006
The Therapeutic Goods Administration (TGA) Group of Regulators, which includes the TGA, the Office of the Gene Technology Regulator and the Office of Chemical Safety - incorporating the National Industrial Chemicals Notification and Assessment Scheme (NICNAS), is responsible for the regulation of therapeutic products, chemicals and gene technology in Australia.
The TGA Group of Regulators Business Plan 2005-2006 is an integral part of the framework that will guide the work of the Group during the 2005-2006 financial year. The Plan includes the specific targets that will be the focus for each operational area for 2005-06, and how they will be achieved.
TGA Group of Regulators business plan July 2005 - June 2006 (pdf, 146kb)
Contents
- Introduction
- Corporate overview
- Regulating therapeutic products
- Regulating gene technology
- Regulating chemicals
- Supporting the business
Quarterly reports against the business plan
- TGA Group of Regulators quarterly report against the business plan, April - June 2006 (pdf,239kb)
- TGA Group of Regulators quarterly report against the business plan, January - March 2006 (pdf,231kb)
- TGA Group of Regulators quarterly report against the business plan, October - December 2005 (pdf, 231kb)
- TGA Group of Regulators quarterly report against the business plan, July - September 2005 (pdf, 233kb)